HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gill, D. M. Articles by King, C. A. Search for Related Content PubMed PubMed Citation Articles by Gill, D. M. Articles by King, C. A. Social Bookmarking                      What's this?

JBC, Vol. 250, Issue 16, 6424-6432, Aug, 1975

The mechanism of action of cholera toxin in pigeon erythrocyte lysates

D. M. Gill and C. A. King

The adenylate cyclase activity of intact pigeon erythrocytes begins to rise after about 20 min of exposure to cholera toxin. The maximum rate at which the cyclase activity increases appears to be limited by the number of toxin molecules which can reach an intracellular target. If the erythrocytes are made permeable to the toxin by a bacterial hemolysin, no such limit exists, and adenylate cyclase activity starts to rise immediately upon the addition of toxin, and continues to rise to a maximum at an initially constant rate which is dependent upon the concentration of toxin. On lysed erythrocytes, the addition of cholera antitoxin immediately prevents any further rise in adenylate cyclase activity, but does not reverse any activation already achieved. Erythrocyte lysates may also be activated by isolated peptide A1 of cholera toxin, although activation of adenylate cyclase of intact erythrocytes requires the complete toxin molecule. In the intact cells, toxin first attaches by its Component B to surface receptors of which there are about 30 per erythrocyte. Subsequently, peptide A1 but not Component B is inserted into the erythrocyte. It takes only about 1 min at 37 degrees for peptide A1 to be sufficiently deep within the cell membrane to be inaccessible to extracellular antitoxin, but its complete transit through the membrane appears to take longer. The surface receptors are used only once, for they remain blocked by Component B. The number of receptors available on the surface may be increased by soaking cells in ganglioside GM1. Cholera toxin also decreases the rate of apparently spontaneous loss of adenylate cyclase activity and increases the response to epinephrine. Theophylline inhibits the action of cholera toxin.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Olsnes, O. Klingenberg, and A. Wiedlocha Transport of Exogenous Growth Factors and Cytokines to the Cytosol and to the Nucleus Physiol Rev, January 1, 2003; 83(1): 163 - 182. [Abstract] [Full Text] [PDF]

				Y. M. Murley, P. A. Carroll, K. Skorupski, R. K. Taylor, and S. B. Calderwood Differential Transcription of the tcpPH Operon Confers Biotype-Specific Control of the Vibrio cholerae ToxR Virulence Regulon Infect. Immun., October 1, 1999; 67(10): 5117 - 5123. [Abstract] [Full Text] [PDF]

				M. Yamamoto, H. Kiyono, S. Yamamoto, E. Batanero, M.-N. Kweon, S. Otake, M. Azuma, Y. Takeda, and J. R. McGhee Direct Effects on Antigen-Presenting Cells and T Lymphocytes Explain the Adjuvanticity of a Nontoxic Cholera Toxin Mutant J. Immunol., June 15, 1999; 162(12): 7015 - 7021. [Abstract] [Full Text] [PDF]

				E. T. Ryan, T. I. Crean, M. John, J. R. Butterton, J. D. Clements, and S. B. Calderwood In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae Infect. Immun., April 1, 1999; 67(4): 1694 - 1701. [Abstract] [Full Text] [PDF]

				M. Yamamoto, D. E. Briles, S. Yamamoto, M. Ohmura, H. Kiyono, and J. R. McGhee A Nontoxic Adjuvant for Mucosal Immunity to Pneumococcal Surface Protein A J. Immunol., October 15, 1998; 161(8): 4115 - 4121. [Abstract] [Full Text] [PDF]

				R. L. Brandão, I. M. Castro, E. A. Bambirra, S. C. Amaral, L. G. Fietto, M. J. M. Tropia, M. J. Neves, R. G. Dos Santos, N. C. M. Gomes, and J. R. Nicoli Intracellular Signal Triggered by Cholera Toxin in Saccharomyces boulardii and Saccharomyces cerevisiae Appl. Envir. Microbiol., February 1, 1998; 64(2): 564 - 568. [Abstract] [Full Text]

				S. Yamamoto, H. Kiyono, M. Yamamoto, K. Imaoka, M. Yamamoto, K. Fujihashi, F. W. Van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity PNAS, May 13, 1997; 94(10): 5267 - 5272. [Abstract] [Full Text] [PDF]

				S. Yamamoto, Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, M. Yamamoto, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity J. Exp. Med., April 7, 1997; 185(7): 1203 - 1210. [Abstract] [Full Text] [PDF]

				A Kurosky, D. Markel, J. Peterson, and W. Fitch Primary structure of cholera toxin beta-chain: a glycoprotein hormone analog? Science, January 21, 1977; 195(4275): 299 - 301. [Abstract] [PDF]

				P. Fishman and R. Brady Biosynthesis and function of gangliosides Science, November 26, 1976; 194(4268): 906 - 915. [Abstract] [PDF]

				N. Morinaga, Y. Kaihou, N. Vitale, J. Moss, and M. Noda Involvement of ADP-ribosylation Factor 1 in Cholera Toxin-induced Morphological Changes of Chinese Hamster Ovary Cells J. Biol. Chem., June 15, 2001; 276(25): 22838 - 22843. [Abstract] [Full Text] [PDF]